There are five libraries in this category: Approved Drug Library, Clinical Compound Library, Drug Repurposing Library, FDA-Approved Drug Library, and Preclinical Compound Library. The purpose of such screening collections is to enable rapid testing of compounds with demonstrated safety profiles in new indications, such as neglected or rare diseases, where there is less commercial motivation for expensive research and development.
Cat No. | product name | ||
---|---|---|---|
L1000 | Approved Drug Library | A unique collection of 2342 approved drugs for high throughput screening (HTS) and high content screening (HCS); | 2342 compounds |
L3400 | Clinical Compound Library | A unique collection of 1487 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS); | 1487 compounds |
L4200 | FDA-approved Drug Library | A unique collection of 1436 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS); | 1436 compounds |
L3410 | Preclinical Compound Library | A unique collection of 450 preclinical compounds for high throughput screening (HTS) and high content screening (HCS); | 450 compounds |
L9200 | Drug Repurposing Library | A unique collection of 3272 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS); | 3272 compounds |
L1010 | FDA Approved & Pharmacopeial Drug Library | 2950 compounds from marketed drugs for high throughput screening (HTS) and high content screening (HCS); | 2950 compounds |